2. Academic Validation
  3. Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy

Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy

  • Eur J Med Chem. 2024 Mar 4:269:116288. doi: 10.1016/j.ejmech.2024.116288.
Chenyu Liu 1,  Yang Li 1,  Zhihao Liu 2,  Chenxi Cao 3,  Min Lin 2,  Xin Chen 2,  Mengting Yuan 2,  Yaohua Fan 3,  Xiaodong Gu 3,  Lei Wang 2,  Fan Yang 4,  Fei Ye 5,  Jia Jin 6
Affiliations

Affiliations

  • 1 Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200062, China.
  • 2 College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
  • 3 Department of Oncology, The Second Affiliated Hospital of Jiaxing University, No. 397, Huangcheng North Road, Jiaxing, 314000, China.
  • 4 Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200062, China. Electronic address: fyang@chem.ecnu.edu.cn.
  • 5 College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. Electronic address: yefei@zstu.edu.cn.
  • 6 College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. Electronic address: aukaukauk@163.com.
PMID: 38460270 DOI: 10.1016/j.ejmech.2024.116288
Abstract

Coactivator-associated arginine methyltransferase 1 (CARM1) plays an important role in cell proliferation and gene expression, and is highly expressed in a variety of tumor tissues. Guided by our previous reported structure of DCPR049_12, we focused on designing and evaluating selective CARM1 inhibitors, resulting in the identification of compound 11f as a promising lead candidate. Compound 11f displayed potent inhibition of CARM1 (IC50 = 9 nM). Comprehensive evaluations, including in vitro metabolic stability assessments, molecular modelling, cellular studies, and in vivo anti-tumor studies, confirmed that it induced Cancer cell Apoptosis and specifically inhibited CARM1's methylation function. Notably, compound 11f displayed significant anti-proliferative effects on colorectal Cancer cell lines, showcasing its potential for targeted therapies against CARM1-related diseases. This study provides valuable insights for the future development of specific and effective CARM1 inhibitors.

Keywords

Antitumor; Arginine methyltransferase; Inhibitor; Methylate; PRMTs.

Figures
Products